Guardian Pharmacy Services, Inc. (GRDN) SEC Filings & Earnings Calls

Lock-up expiration in Sep 2027 could lead to selling pressure.

“Lock-Up Holders have agreed not to...dispose of...shares...through September 14, 2027.”

IRA-related pricing reductions pressure reported revenue growth; underlying growth stronger but masked.

“IRA-related pricing reductions affected reported revenue growth, which was up 2%.” · word for word

Dependence on payor settlement for net income boost; $8.5M settlement non-recurring.

“Net Income of $22.1 million, inclusive of a $8.5 million settlement related to a payor dispute.” · word for word

IRA pricing pressure continues

“We expect IRA-related price reductions to continue impacting year-over-year comparability throughout the remainder of 2026.” · word for word

SG&A deleverage

“Selling, general and administrative expenses as a percentage of revenue increased from 16.1% to 16.9% based primarily on Selling, general and administrative expenses increasing at a higher rate than revenue during the three months ended June 30, 2026 as a result of the IRA price changes.” · word for word

Potential disruption from executive transitions, though internal promotions may mitigate risk.

“Retirement of EVP Sales & Operations and CFO transition.”

Increased leverage capacity could lead to higher debt if utilized.

“Creation of a Direct Financial Obligation... increasing leverage.”

IRA drug pricing pressure on revenue

“Organic revenue decreased by $11.2 million, primarily attributable to pricing decreases as a result of the IRA.” · word for word

Concentration in long-term care facilities

“More than two-thirds of annual revenue from ALFs and BHFs; any downturn in these segments could impact results.”

Payor reimbursement risk

“The company recorded $3.3M in payor-reimbursement matters in Q1 2026, indicating ongoing disputes.”

IRA pricing resets on branded medications could pressure margins.

“IRA introduced significant pricing resets; offset achieved in Q1.”

Insider selling / ownership dilution

“On March 20, 2026, the Reporting Persons sold an aggregate amount of 5,880,000 shares of Class A common stock of the Issuer...the Underwriters exercised in full their option to purchase an additional 900,000 shares of Class A common stock from the Reporting Persons.” · word for word

Insider selling / ownership dilution

“On March 20, 2026, the Reporting Persons sold an aggregate amount of 5,880,000 shares of Class A common stock of the Issuer...the Underwriters exercised in full their option to purchase an additional 900,000 shares of Class A common stock from the Reporting Persons.” · word for word

Loss of controlled company status may lead to increased governance requirements.

“Company ceased to qualify as a controlled company; will need to comply with NYSE corporate governance rules.” · word for word

Controlled Company Governance Risk

“The Guardian Founders own more than 50% of the total voting power of our outstanding common stock and we are therefore a 'controlled company' under NYSE corporate governance standards.” · word for word

Concentration of Ownership Risk

“This concentration of ownership may also prevent a change in the composition of our board of directors or a change in control of our company that could deprive our stockholders of an opportunity to receive a premium for their Class A common stock.” · word for word

Limited Public Float Volatility Risk

“As a company with a relatively limited public float, shares of our Class A common stock may experience greater stock price volatility, price run-ups, lower trading volumes, large spreads in bid and ask prices and less liquidity than companies with larger capitalizations.” · word for word

IRA drug pricing changes may pressure revenue growth in 2026, though management maintains revenue guidance.

“As we enter the first quarter under the initial phase of new IRA drug pricing changes, we are maintaining our 2026 revenue outlook provided in mid-January.” · word for word

No new risks identified; standard forward-looking statements.

“Forward-looking statements section”

Integration risk from acquisitions and expansion into new geographies.

“acquisition of Managed Healthcare Pharmacy, establishing its first physical footprint in Oregon” · word for word

Reimbursement pressure

“continuing government and private efforts to lower pharmaceutical costs, including by limiting pharmacy reimbursements” · word for word

Acquisition integration risk

“Our growth strategy involves periodically acquiring institutional pharmacies servicing LTCFs and their residents” · word for word